Scholars Central

Conference abstractPublished 29 Feb 2016

Synthetic derivative of porphyrins as potential anticancer agents

Authors: Jan Habdas

University of Silesia, Poland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Since 1903, when a Danish physician Niels Finsen was awarded the Nobel Prize in Physiology-Medicine for his investigation on applying light as a cure of skin cancer and particularly since 1931, when a German chemist Hans Fischer was awarded the Nobel Prize for his work on haemin synthesis, the interest in synthesis of porphyrins with desired properties and their application in medicine has grown significantly. Additionally, in the second half of the 20th century, photosensitizing properties of porphyrins have been found which combined with the use of laser light and its distribution by fabric optics gave the input for new methods of diagnosis and therapy of cancer. These methods include: Photodynamic Therapy (PDT), Photochemical Antimicrobial Chemotherapy (PACT) and Photodynamic Destroying of Viruses (PDV). Our investigation of using amide, carboxy and phosphono derivatives of meso-tolyl and meso-piridyl porphyrins showed them to be effective photo-sensitizers in the in vitro tests on MEL 45 and SKMEl 188 (human melanoma) causing a decrease in the number of cancer cells up to three-fold. Phosphono derivatives of meso-piridyl porphyrins showed a moderate inhibitory activity towards aminopeptidase-N, which is responsible for tumor cells growth. The in vivo tests on mice manifested some toxic effects which are possible unwanted side effects. A known side effect during human therapy is photosensitivity of patients which lasts from two up to four weeks, during which time the patients need to be kept in dark rooms.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Jan Habdas”